Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R

被引:14
|
作者
Zhang, Zuojun [1 ]
Zhao, Ming [1 ]
Wang, Guojie [1 ]
机构
[1] Luoyang Orthoped Hosp Henan Prov, Upper Limb Injury Treatment Ctr, Orthoped Hosp Henan Prov, Luoyang 471002, Peoples R China
关键词
growth; IGF1R; invasion; lung metastasis; metastasis; microRNA-7; osteosarcoma; promoter methylation; FACTOR RECEPTOR; TUMOR-SUPPRESSOR; MIGRATION; INSULIN; PROLIFERATION; EXPRESSION; INVASION; CANCER; APOPTOSIS;
D O I
10.1002/jcp.28787
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to uncover the methylation of microRNA-7 (miR-7) promoter in osteosarcoma (OS) and the inner mechanism of miR-7 on the progression of OS cells. Expression and methylation state of miR-7 in OS tissues and cells were detected. With the aim to unearth the ability of miR-7 in OS, the proliferation, cell cycle progression, apoptosis, invasion, migration of OS cells, and the tumor growth in nude mice were determined. Meanwhile, IGF1R expression was detected and the association between miR-7 and IGF1R was confirmed. The proliferating cell nuclear antigen (PCNA) expression was tested by immunohistochemical staining, and the lung metastasis was observed by H&E staining. miR-7 expression was decreased and methylation state of miR-7 was increased in OS tissues and cells. Upregulated miR-7 inhibited proliferation, cell cycle progression, invasion,and migration, while inducing apoptosis of OS cells and the tumor growth as well as PCNA expression in nude mice. Expression of IGF1R was downregulated in OS cells with overexpression of miR-7. Experiments verified the binding site between miR-7 and IGF1R. Our study demonstrates that abnormal methylation of miR-7 contributes to decreased miR-7 in OS. In addition, miR-7 represses the initiation and progression of OS cells through the inhibition of IGF1R.
引用
收藏
页码:22195 / 22206
页数:12
相关论文
共 50 条
  • [21] The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
    Vaquero, Javier
    Lobe, Cindy
    Tahraoui, Sylvana
    Claperon, Audrey
    Mergey, Martine
    Merabtene, Fatiha
    Wendum, Dominique
    Coulouarn, Cedric
    Housset, Chantal
    Desbois-Mouthon, Christele
    Praz, Francoise
    Fouassier, Laura
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4282 - 4296
  • [22] IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression
    Lapadula, Dominic
    Lam, Bao
    Terai, Mizue
    Sugase, Takahito
    Tanaka, Ryota
    Farias, Eduardo
    Kadamb, Rama
    Lopez-Anton, Melisa
    Heine, Christian C.
    Modasia, Bhavik
    Aguirre-Ghiso, Julio A.
    Aplin, Andrew E.
    Sato, Takami
    Benovic, Jeffrey L.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (01) : 63 - 74
  • [23] miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma
    Luo, Jie
    Wu, Jianhui
    Li, Zenghong
    Qin, Hao
    Wang, Bin
    Wong, Thian-Sze
    Yang, Weiqiang
    Fu, Qing-Ling
    Lei, Wenbin
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells
    Weinstein, Doron
    Sarfstein, Rive
    Laron, Zvi
    Werner, Haim
    ENDOCRINE CONNECTIONS, 2014, 3 (01) : 24 - 35
  • [25] Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β
    Bielen, Aleksandra
    Perryman, Lara
    Box, Gary M.
    Valenti, Melanie
    Brandon, Alexis de Haven
    Martins, Vanessa
    Jury, Alexa
    Popov, Sergey
    Gowan, Sharon
    Jeay, Sebastien
    Raynaud, Florence I.
    Hofmann, Francesco
    Hargrave, Darren
    Eccles, Suzanne A.
    Jones, Chris
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1407 - 1418
  • [26] ENHANCED EFFICACY OF IGF1R INHIBITION IN PEDIATRIC GLIOBLASTOMA BY COMBINATORIAL TARGETING OF PDGFRα/β
    Bielen, Aleksandra
    Bjerke, Lynn
    Box, Gary
    Valenti, Melanie
    Brandon, Alexis de Haven
    Martins, Vanessa
    Jury, Alexa
    Popov, Sergey
    Gowan, Sharon
    Jeay, Sebastien
    Raynaud, Florence
    Hofmann, Francesco
    Hargrave, Darren
    Eccles, Suzanne
    Jones, Chris
    NEURO-ONCOLOGY, 2011, 13 : I16 - I17
  • [27] Inhibition of the Proliferation and Invasion of C6 Glioma Cells by Tricin via the Upregulation of Focal-Adhesion-Kinase-Targeting MicroRNA-7
    Chung, Dai-Jung
    Wang, Chau-Jong
    Yeh, Chia-Wei
    Tseng, Tsui-Hwa
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (26) : 6708 - 6716
  • [28] IGF1R/IRS PHARMACOLOGICAL INHIBITION REDUCES CELL PROLIFERATION AND MIGRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA CELLS
    Rodrigues Alves, A. P. N.
    Machado-Neto, J.
    Scopim-Ribeiro, R.
    Fernandes, J. C.
    Fenerich, B. A.
    Da Silva, F. B.
    Scheucher, P. S.
    Simoes, B. P.
    Rego, E. M.
    Ridley, A. J.
    Traina, F.
    HAEMATOLOGICA, 2017, 102 : 343 - 343
  • [29] IGF Signalling Is Critical for Growth and Survival of T-Cell Acute Lymphoblastic Leukemia Cells and Is Potentiated by Notch Upregulation of IGF1R
    Medyouf, Hind
    Gusscott, Samuel
    Wai, Carol
    Leung, Marcus
    Armstrong, Florence
    Pflumio, Francoise
    Pollak, Michael
    Weng, Andrew P.
    BLOOD, 2008, 112 (11) : 1303 - 1303
  • [30] MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways
    Zhao, Jun-gang
    Men, Wan-fu
    Tang, Jun
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (03): : 201 - 206